FIELD: medicine, oncology.
SUBSTANCE: the suggested method deals with biochemical studying in malignant tumor and endometrial tissues, moreover, both before and after carrying out complex therapy one should detect activity of cathepsin D and acid-stable inhibitors, calculate the coefficient for the ratio of cathepsin D to acid-stable inhibitors and at coefficient values being above those characteristic for the tissue of intact endometrium by more than 2.4-2.8 times it is possible to predict relapse development for the terms of 6 mo. Thus , the present innovation enables to detect the development of pathological process before its clinical manifestation.
EFFECT: higher efficiency of prediction.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RECURRENT ENDOMETRIAL CANCER PREDICTION BASED ON PTEN AND CYP1B1 GENES EXPRESSION LEVEL | 2015 |
|
RU2605302C1 |
| METHOD FOR PREDICTION OF ENDOMETRIAL CANCER PATIENTS SURVIVAL ON THE BASIS OF THE ESR1 GENE EXPRESSION LEVEL | 2015 |
|
RU2611352C1 |
| TEST-SYSTEM FOR PREDICTION OF RELAPSE DEVELOPMENT IN PATIENTS WITH UTERINE CORPUS CANCER BASED ON EXPRESSION LEVEL OF THE ESR1 GENE | 2017 |
|
RU2661599C1 |
| METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMOTHERAPY IN CASE OF LOCALLY ADVANCED OVARIAN CARCINOMA | 2008 |
|
RU2383339C1 |
| METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
| METHOD OF PREDICTING DEVELOPMENT OF METACHRONOUS HYPERPLASTIC PROCESSES IN ORGANS OF FEMALE REPRODUCTIVE SYSTEM | 2010 |
|
RU2436517C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN UTERINE CANCER PATIENTS BASED ON ANALYSIS OF MAGEA1, MAGEB2 AND PRAME1 GENE EXPRESSION | 2018 |
|
RU2698895C1 |
| METHOD FOR PERSONALISING TREATMENT OF YOUNG PATIENTS SUFFERING ENDOMETRIAL CANCER | 2011 |
|
RU2508550C2 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
| METHOD OF DETERMINATION OF ORIENTATION OF PATHOLOGICAL PROCESS AT CANCER OF OVARIES | 2007 |
|
RU2350966C1 |
